Published in J Virol on November 01, 2000
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88
Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol (2005) 7.36
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog (2007) 4.99
Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol (2002) 4.87
H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog (2008) 4.79
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00
Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol (2005) 2.97
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
Novel reassortant highly pathogenic H5N2 avian influenza viruses in poultry in China. PLoS One (2012) 2.43
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol (2010) 2.35
Influenza: emergence and control. J Virol (2004) 2.31
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J Virol (2002) 2.05
Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A (2004) 1.91
Animal models for the study of influenza pathogenesis and therapy. Antiviral Res (2009) 1.90
Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J Virol (2002) 1.85
Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerg Infect Dis (2011) 1.82
Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol (2003) 1.62
A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice. J Virol (2009) 1.56
The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One (2009) 1.55
Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One (2009) 1.53
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res (2008) 1.47
Sequences in influenza A virus PB2 protein that determine productive infection for an avian influenza virus in mouse and human cell lines. J Virol (2001) 1.42
Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol (2012) 1.37
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol (2009) 1.32
Early control of H5N1 influenza virus replication by the type I interferon response in mice. J Virol (2009) 1.24
Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol (2006) 1.24
PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. J Virol (2011) 1.22
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine (2009) 1.16
Molecular evolution of the H6 subtype influenza A viruses from poultry in eastern China from 2002 to 2010. Virol J (2011) 1.15
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J Virol (2009) 1.06
Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J Virol (2011) 1.03
Ostrich involvement in the selection of H5N1 influenza virus possessing mammalian-type amino acids in the PB2 protein. J Virol (2009) 1.01
Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol (2010) 1.01
Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J Virol (2010) 1.01
Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog (2010) 1.00
Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and Mice. J Virol (2015) 1.00
The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage. J Virol (2013) 0.99
Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys. J Biomed Sci (2010) 0.95
Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus. J Biol Chem (2013) 0.91
Continuing Reassortant of H5N6 Subtype Highly Pathogenic Avian Influenza Virus in Guangdong. Front Microbiol (2016) 0.90
Molecular epidemiology of influenza A/H3N2 viruses circulating in Uganda. PLoS One (2011) 0.90
iHAT: interactive hierarchical aggregation table for genetic association data. BMC Bioinformatics (2012) 0.90
Pathogenicity of swine influenza viruses possessing an avian or swine-origin PB2 polymerase gene evaluated in mouse and pig models. Virology (2010) 0.88
The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals. Vet Res (2010) 0.84
Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol (2014) 0.81
Reassortment of Avian Influenza A/H6N6 Viruses from Live Poultry Markets in Guangdong, China. Front Microbiol (2016) 0.79
Characterization of H5N1 influenza viruses isolated from humans in vitro. Virol J (2010) 0.79
Immunization with live virus vaccine protects highly susceptible DBA/2J mice from lethal influenza A H1N1 infection. Virol J (2012) 0.78
Isolation and characterization of H9N2 influenza virus isolates from poultry respiratory disease outbreak. Springerplus (2014) 0.78
Pathobiological Characterization of a Novel Reassortant Highly Pathogenic H5N1 Virus Isolated in British Columbia, Canada, 2015. Sci Rep (2016) 0.77
H9N2 low pathogenic avian influenza in Pakistan (2012-2015). Vet Rec Open (2016) 0.76
Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus. Sci Rep (2016) 0.75
Pathogenesis and Phylogenetic Analyses of Two Avian Influenza H7N1 Viruses Isolated from Wild Birds. Front Microbiol (2016) 0.75
The pathogenicity of swan derived H5N1 virus in birds and mammals and its gene analysis. Virol J (2014) 0.75
Additional Evidence That the Polymerase Subunits Contribute to the Viral Replication and the Virulence of H5N1 Avian Influenza Virus Isolates in Mice. PLoS One (2015) 0.75
Two Genetically Similar H9N2 Influenza A Viruses Show Different Pathogenicity in Mice. Front Microbiol (2016) 0.75
Molecular determinants of influenza virus pathogenesis in mice. Curr Top Microbiol Immunol (2014) 0.75
Characterization of Variations in PB2, NS1, M, Neuraminidase and Hemagglutinin of Influenza A (H3N2) Viruses in Iran. Jundishapur J Microbiol (2014) 0.75
Biological Characterizations of H5Nx Avian Influenza Viruses Embodying Different Neuraminidases. Front Microbiol (2017) 0.75
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet (1998) 16.30
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet (1998) 12.89
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol (1993) 10.22
A pandemic warning? Nature (1997) 8.70
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol (1998) 5.48
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature (1983) 5.11
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
A single gene determines the host range of influenza virus. Nature (1977) 3.43
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A (1998) 2.86
Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol (2000) 2.84
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J Infect Dis (1998) 2.66
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol (1993) 2.40
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol (1988) 2.35
Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol (1996) 2.17
Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J Virol (1993) 2.15
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.99
Virulence of influenza A virus for mouse lung. Virus Genes (1997) 1.53
Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res (1999) 1.51
Characterization of low virulent strains of highly pathogenic A/Hong Kong/156/97 (H5N1) virus in mice after passage in embryonated hens' eggs. Virology (2000) 1.42
Role of neuraminidase in influenza virus-induced apoptosis. J Gen Virol (1999) 1.41
Evolutionary characterization of the six internal genes of H5N1 human influenza A virus. J Gen Virol (2000) 1.37
Neurovirulence of influenza A virus. J Neurovirol (1996) 1.35
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Global epidemiology of influenza: past and present. Annu Rev Med (2000) 7.80
Predicting the evolution of human influenza A. Science (1999) 6.91
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet (2001) 5.67
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36
Influenza. Lancet (1999) 4.77
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes. Virus Res (2000) 4.65
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A (1998) 3.88
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci (1968) 3.78
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
Parallel neural networks for learning sequential procedures. Trends Neurosci (1999) 3.35
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
The Caenorhabditis elegans locus lin-15, a negative regulator of a tyrosine kinase signaling pathway, encodes two different proteins. Genetics (1994) 3.09
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature (2001) 3.07
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92
Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med (1966) 2.86
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (1995) 2.79
Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain (1976) 2.76
Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem (1998) 2.67
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
Congenital Aniridia. Am J Hum Genet (1960) 2.50
Regulation of Hsp70 function by a eukaryotic DnaJ homolog. J Biol Chem (1992) 2.46
Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci U S A (2000) 2.42
Imaging exocytosis and endocytosis. Curr Opin Neurobiol (1996) 2.41
Use of gentamicin in combinations with other antibiotics. J Infect Dis (1969) 2.37
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35
Activation of posterior gap gene expression in the Drosophila blastoderm. Nature (1995) 2.30
CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res (1999) 2.27
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
Zim1, a maternally expressed mouse Kruppel-type zinc-finger gene located in proximal chromosome 7. Hum Mol Genet (1999) 2.20
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
Deep mantle cycling of oceanic crust: evidence from diamonds and their mineral inclusions. Science (2011) 2.09
Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol (1968) 2.07
Polymorphism of human C-band heterochromatin. I. Frequency of variants. Am J Hum Genet (1973) 2.04
In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients. Antimicrob Agents Chemother (1972) 2.02
Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis (1999) 2.02
Mycoplasma pneumoniae infections in volunteers. Ann N Y Acad Sci (1967) 1.98
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J Immunol (1997) 1.95
ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer (2007) 1.94
An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol (1995) 1.92
Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc Natl Acad Sci U S A (1998) 1.91
IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol (1992) 1.90
Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A (1982) 1.85
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev (1997) 1.85
AsMamDB: an alternative splice database of mammals. Nucleic Acids Res (2001) 1.85
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology (1995) 1.80
Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. J Immunol (1967) 1.79
Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum (1981) 1.79
Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med (1974) 1.78
Identification and characterization of a serine-like proteinase of the murine coronavirus MHV-A59. J Virol (1995) 1.76
Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs. Proc Natl Acad Sci U S A (1987) 1.75
Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci (1998) 1.74
A functional protein pore with a "retro" transmembrane domain. Protein Sci (1999) 1.73
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost (2012) 1.69
Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med (1967) 1.67
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med (1998) 1.64
Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.64
Low-temperature-grown RS virus in adult volunteers. JAMA (1968) 1.63
Specific banding patterns of human chromosomes. Proc Natl Acad Sci U S A (1971) 1.63
Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J Virol (2006) 1.63
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine (2003) 1.61
Renal insufficiency associated with gentamicin therapy. J Infect Dis (1971) 1.59
Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair. Mol Cell Biol (1995) 1.59
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Haemophilus influenzae and haemophilus parainfluenzae in chronic obstructive pulmonary disease. Lancet (1976) 1.57
Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. JAMA (1967) 1.56
Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol Vis Sci (1990) 1.55
Educating girls. Finance Dev (1992) 1.55
Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem (1994) 1.55
The work by the developing primary care team in China: a survey in two cities. Fam Pract (2000) 1.54
Apoptosis in barley aleurone during germination and its inhibition by abscisic acid. Plant Mol Biol (1996) 1.54
Primary carbonatite melt from deeply subducted oceanic crust. Nature (2008) 1.53
Validity of utilization management criteria for psychiatry. Am J Psychiatry (1997) 1.53
Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. Biochem J (2001) 1.51
Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ (2011) 1.51
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J Infect Dis (1997) 1.51
Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology (1996) 1.50
G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol (1997) 1.49
Conditional prospective rights of the fetus. J Leg Med (1984) 1.48
Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc Natl Acad Sci U S A (1997) 1.46
Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol (2000) 1.45
Meatal colonization and catheter-associated bacteriuria. N Engl J Med (1980) 1.45